|
1）Koyak Z, Harris L, de Groot JR, et al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012; 126: 1944-54
|
|
|
|
2）Verheugt CL, Uiterwaal CS, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010; 31: 1220-9
|
|
|
|
|
|
3）Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythmia Electrophysiol. 2008; 1: 250-7
|
|
|
|
|
|
4）Yap SC, Harris L, Chauhan VS, et al. Identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am J Cardiol. 2011; 108: 723-8
|
|
|
|
|
|
5）Walsh EP. Sudden death in adult congenital heart disease: risk stratification in 2014. Heart Rhythm. 2014; 11: 1735-42
|
|
|
|
|
|
6）Gallego P, Gonzalez AE, Sanchez-Recalde A, et al. Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. Am J Cardiol. 2012; 110: 109-17
|
|
|
|
|
|
7）Gatzoulis MA, Till JA, Somerville J et al. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995; 92: 231-7
|
|
|
|
|
|
8）Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000; 356: 975-81
|
|
|
|
|
|
9）Diller GP, Kempny A, Liodakis E, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot. Circulation. 2012; 125: 2440-6
|
|
|
|
|
|
10）Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008; 117: 363-70
|
|
|
|
|
|
11）Khairy P, Aboulhosn J, Gurvitz MZ, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010; 122: 868-75
|
|
|
|
|
|
12）Moore JP, Seki A, Shannon KM, et al. Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythm Electrophysiol. 2013; 6: 905-11
|
|
|
|
|
|
13）Kapel GF, Reichlin T, Wijnmaalen AP, et al. Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol. 2015; 8: 102-9
|
|
|
|
|
|
14）Kapel GF, Reichlin T, Wijnmaalen AP, et al. Left-sided ablation of ventricular tachycardia in adults with repaired tetralogy of Fallot: a case series. Circ Arrhythm Eelectrophysiol. 2014; 7: 889-97
|
|
|
|
|
|
15）Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004; 109: 1994-2000
|
|
|
|
|
|
16）Ohuchi H, Miyazaki A, Watanabe T, et al. Hemodynamic deterioration during simulated supraventricular tachycardia in patients after the Fontan operation. Int J Cardiol. 2007; 117: 381-7
|
|
|
|
|
|
17）Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008; 117: 85-92
|
|
|
|
|
|
18）Kammeraad JA, van Deurzen CH, Sreeram N, et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004; 44: 1095-102
|
|
|
|
|
|
19）Ohuchi H, Watanabe K, Kishiki K, et al. Heart rate dynamics during and after exercise in postoperative congenital heart disease patients. Their relation to cardiac autonomic nervous activity and intrinsic sinus node dysfunction. Am Heart J. 2007; 154: 165-71
|
|
|
|
|
|
20）Sherwin ED, Triedman JK, Walsh EP. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythm Eelectrophysiol. 2013; 6: 1032-40
|
|
|
|
|
|
21）Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014; 11: e102-65
|
|
|
|
|
|
22）Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225-37
|
|
|
|
|
|
23）Kowalski M, Nicolato P, Kalahasty G, et al. An alternative technique of implanting a nontransvenous implantable cardioverter-defibrillator system in adults with no or limited venous access to the heart. Heart Rhythm. 2010; 7: 1572-7
|
|
|
|
|
|
24）Radbill AE, Triedman JK, Berul CI, et al. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm. 2010; 7: 193-8
|
|
|
|
|
|
25）Burke MC, Gold MR, Knight BP, et al. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol. 2015; 65: 1605-15
|
|
|
|
|
|
26）Jarman JW, Lascelles K, Wong T, et al. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J. 2012; 33: 1351-9
|
|
|
|
|
|
27）Waller JR, Salmon AP, Roberts PR. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease. Europace. 2015; 17: 77
|
|
|
|
|
|
28）Peters B, Will A, Berger F, et al. Implantation of a fully subcutaneous ICD in a patient with single ventricle morphology and Eisenmenger physiology. Acta Cardiologica. 2012; 67: 473-5
|
|
|
|
|